Michael Mack, MD - TAVI [Giants Interview]
Myocardial Revascularization without Cardiopulmonary Bypass [Book Chapter]
Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial [Journal]
Dr. Michael Mack is the current president of the Society of Thoracic Surgeons. He is Medical Director at Dallas Hospital where he has been a practicing surgeon for 28 years. He is on staff at several hospitals in Texas and has Visiting Professorships in China, Brazil, Egypt, and Sweden. Dr. Mack has given more than 150 presentations on cardiac and thoracic surgery in over 30 countries. He is on the steering committee of the PARTNER Trial and of the world’s largest two surgical revascularization trials, namely the SYNTAX trial and the EXCEL trial. His particular techniques and tips for coronary artery bypass grafting are the subjects of this interview.
Publication Date: 27-Sep-2011
Last Modified: 26-Sep-2011